Back to search
HSV-2 Infection
Clinical trial pipeline · Data from ClinicalTrials.gov
See which HSV-2 Infection trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which HSV-2 Infection trials you may qualify forThis phase I study evaluates the safety and efficacy of OH2 as single agent or in combination with Keytruda, an anti-PD-1 antibody, in patients with malignant s…
This phase Ib study evaluates the safety and efficacy of OH2 in combination with HX008, an anti-PD-1 antibody, in patients with Melanoma. OH2 is an oncolytic v…
The purpose of this study is to generate safety and immunogenicity data and establish a proof-of-concept of clinical benefit of the mRNA-1608 vaccine candidate.
This study is designed to assess safety, tolerability, and pharmacokinetics (PK) of single ascending dose (SAD) of ABI-5366 in Part A in healthy participants an…